Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 10
Submit an article Journal homepage
388
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1–2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database

Karim E. Abou-NassarDépartement d’Hématologie, Centre de santé et de services sociaux de Gatineau, Gatineau, QC, Canada
,
Ann VanderplasBiostatistics Center, City of Hope National Medical Center, Duarte, CA, USA
,
Jonathan W. FriedbergJames P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA
,
Gregory A. AbelDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
,
Joyce NilandData Coordinating Center, City of Hope National Medical Center, Duarte, CA, USA
,
Maria A. RodriguezM. D. Anderson Cancer Center, Houston, TX, USA
,
Myron S. CzuczmanRoswell Park Cancer Institute, Buffalo, NY, USA
,
Michael MillensonFox Chase Cancer Center, Philadelphia, PA, USA
,
Allison CrosbyDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
,
Leo I. GordonHematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
,
Andrew D. ZelenetzMemorial Sloan-Kettering Cancer Center, New York, NY, USA
,
Mark KaminskiUniversity of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
&
Ann S. LacasceDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]
 show all
Pages 2155-2162 | Received 25 Jul 2012, Accepted 22 Jan 2013, Published online: 25 Feb 2013

References

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909–3918.
  • Czuczman MS. Controversies in follicular lymphoma: “who, what, when, where, and why?” (not necessarily in that order!). Hematology Am Soc Hematol Educ Program 2006:303–310.
  • Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258–1265.
  • Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol 2009;27:1202–1208.
  • MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282–1290.
  • Guadagnolo BA, Li S, Neuberg D, et al. Long-term outcome and mortality trends in early-stage, grade 1–2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006;64:928–934.
  • Wilder RB, Jones D, Tucker SL, et al. Long-term results with radiotherapy for stage I–II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001;51:1219–1227.
  • Pendlebury S, el Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol 1995;36:167–171.
  • Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994;69:1088–1093.
  • Cheson BD, Pfistner B, Juweid ME, et al. International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. Clin Oncol 2007;25:579–586.
  • Najjar F, Hustinx R, Jerusalem G, et al. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL). Cancer Biother Radiopharm 2001;16:297–304.
  • Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875–3876.
  • Wohrer S, Jaeger U, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 2006;17:780–784.
  • Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001;12:825–830.
  • Jerusalem GH, Beguin YP. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clin Lymphoma 2002;3:56–61.
  • Wirth A, Foo M, Seymour JF, et al. Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2008;71:213–219.
  • Fueger BJ, Yeom K, Czernin J, et al. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin’s lymphoma. Mol Imaging Biol 2009;11:269–274.
  • Schoder H, Noy A, Gonen M, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005;23:4643–4651.
  • Janikova A, Bolcak K, Pavlik T, et al. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?. Clin Lymphoma Myeloma 2008;8:287–293.
  • Zelenetz AD, Abramson JS, Advani RH, et al. NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. J Natl Compr Canc Netw 2010;8:288–334.
  • Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluorodeoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006;107:175–183.
  • Le Dortz L, De Guibert S, Bayat S, et al. Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 2010;37:2307–2314.
  • Trotman J, Fournier M, Lamy T, et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 2011;29:3194–3200.
  • Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA 2010;303:1625–1631.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.